Further investigation of the developing link between circadian rhythms, diabetes, and obesity [[49], [50], [51]] and improved understanding of the molecular drivers behind the circadian secretion of GLP-1 may therefore have therapeutic implications, including time-sensitive therapies. This evidence concerns the gene GCG and diabetes mellitus.